Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns

EClinicalMedicine(2023)10.1016/j.eclinm.2023.102268Source: DataRank Database

Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns is a research paper published in EClinicalMedicine (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 1.36)OA: goldTopics (25)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (28)

Yimei Li ORCID,Snehit Prabhu ORCID,Christina Baggott ORCID,Khanh Nguyen ORCID,Holly Pacenta

Live enrichment

PubMed:37954907 PMC:PMC10632672 OpenAlex:https://openalex.org/W4388200920

National Institutes of Health

Grant: UL1 TR001085

FDA HHS

Grant: U01 FD005978

NCI NIH HHS

Grant: P30 CA008748

Entertainment Industry Foundation

National Center for Advancing Translational Sciences

Saint Baldricks Foundation

American Association for Cancer Research

Stanford University

National Center for Research Resources

Parker Institute for Cancer Immunotherapy

Stand Up To Cancer

Virginia and D K Ludwig Fund for Cancer Research

FWCI

1.36

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.thelancet.com/article/S2589537023004455/pdf

publisherhttp://www.thelancet.com/article/S2589537023004455/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2589537023004455?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2589537023004455?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.eclinm.2023.102268

Fields of Study

CAR-T cell therapy researchAcute Lymphoblastic Leukemia researchVirus-based gene therapy research

Keywords

MedicineRefractory (planetary science)Internal medicineRetrospective cohort studyCytokine release syndromeCohortBlinatumomabOncologyReal world dataPediatricsChimeric antigen receptorLeukemiaImmunotherapyLymphoblastic LeukemiaCancerFirst RelapsePediatric OncologyCar T CellsCd19 Car T CellsReal-world AnalysisTisagenlecleucelCommercial Car

Sustainable Development Goals

SDG 0: Zero hunger